AVITA Medical (AVHHL) Other Non-Current Liabilities (2019 - 2026)
AVITA Medical's (AVHHL) quarterly Other Non-Current Liabilities came in at $879000.0 in Q2 2026, down 53.74% on a YoY basis from $1.9 million in Q2 2025, and down 70.7% quarter-over-quarter from $3.0 million in Q4 2025.
Analysis
AVITA Medical (AVHHL) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
AVITA Medical (AVHHL) has reported Other Non-Current Liabilities for 7 consecutive years, with $879000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities fell 53.74% year-over-year to $879000.0; the trailing twelve-month figure through Jun 2026 stood at $879000.0 (down 53.74% YoY), and the FY2025 full-year result was $3.0 million, down 12.59% from the prior year.
- Other Non-Current Liabilities declined to $879000.0 in Q2 2026 per AVHHL's latest filing, from $3.0 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $4.0 million in Q1 2024 and bottomed at $571000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $2.2 million across 5 years, with a median of $2.0 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities surged 2905.26% in 2022, then slumped 53.74% in 2026.
- Over 5 years, Other Non-Current Liabilities stood at $1.3 million in 2022, then soared by 134.27% to $3.2 million in 2023, then advanced by 8.68% to $3.4 million in 2024, then retreated by 12.59% to $3.0 million in 2025, then tumbled by 70.7% to $879000.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $879000.0, $3.0 million, and $1.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 185.64 Bn | 180.04 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.84 Bn | 120.62 Bn | 1.96 Bn |
| 3 | Medtronic | 119.28 Bn | 110.46 Bn | 6.34 Bn |
| 4 | Stryker | 105.87 Bn | 102.40 Bn | 4.50 Bn |
| 5 | Boston Scientific | 67.67 Bn | 67.13 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 50.04 Bn | 45.79 Bn | 1.35 Bn |
| 7 | Alcon | 34.11 Bn | 32.65 Bn | 1.68 Bn |
| 8 | Dexcom | 32.16 Bn | 30.21 Bn | 830.00 Mn |
| 9 | Steris | 21.21 Bn | 20.73 Bn | 684.20 Mn |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 879,000.00 |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 3.43 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 4.03 Mn |
| Dec 31, 2023 | 3.16 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Jun 30, 2022 | 715,000.00 |
| Mar 31, 2022 | 571,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Sep 30, 2021 | 503,000.00 |
| Jun 30, 2021 | 503,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Jun 30, 2019 | 42,000.00 |